| Fecha | Trimestre | Sesión | BPA (est → real) | Ingresos (est → reales) |
|---|---|---|---|---|
| 28 oct 2026Próximo | Q3 2026 | Antes de apertura | 7,72 | 74,9 B |
27 ago 2026
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 1.25% on an annualized basis producing an average annual return of 10.49%. Currently, Cigna Group has a market capitalization of $73.46
CI's Smart Coverage links medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events.
26 ago 2026
Cigna has been treading water for the past six months, recording a small loss of 3.5% while holding steady at $278.80. The stock also fell short of the S&P 500’s 10.8% gain during that period.
Cigna Healthcare®, the health benefits division of The Cigna Group (NYSE: CI), is introducing a new connected benefits experience that helps people pay for costs associated with unexpected or costly health events by bringing medical and supplemental health benefits together in a simpler, more personalized way.
By linking medical and supplemental health benefits, the new solution reduces administrative complexity and helps customers identify and use their available benefits. It also makes it easier to access cash benefits tied
25 ago 2026
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
24 ago 2026
An aging U.S. population, digital transformation, a diversified membership mix and strategic M&A are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
23 ago 2026
Cigna Group stock reacts to TestMu Conference spotlight on AI and reliability Cigna Group (CI) is in focus after the company scheduled a presentation at the 5th TestMu Conference on August 19, 2026, featuring AI and automation engineering lead Nagarjun Adikesavan. The event highlights Cigna Group’s emphasis on quality and reliability in AI driven systems, which matters for investors who are watching how large health insurers apply automation to complex pharmacy and medical benefit...
Cigna Group stock has delivered a 44.4% gain over the past five years, yet the broader valuation checks still suggest the shares screen as undervalued at the recent price of US$277.51. With shorter term returns weaker, investors are left weighing a mixed share price history against a still supportive valuation read. Over five years, Cigna Group has returned 44.4%, which points to solid long term wealth creation despite more recent share price softness. Expectations for the company to keep...
19 ago 2026
CI's growth and shareholder returns are weighed against rising costs, medical expenses and debt, keeping investors neutral for now.
17 ago 2026
Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.
Cigna stock is a "Buy" as Accredo & AI-powered Pharmacy Forward drive EPS growth. Here's what investors need to know.
